Results 31 to 40 of about 62,561 (290)
Objective: Clinical parameters for prediction of post-stroke spasticity are well established. This report introduces 2 brain magnetic resonance imaging (MRI) parameters (infarct volume and topographic distribution) as post-stroke spasticity predictors ...
Songjin Ri +4 more
doaj +1 more source
Paroxysmal Kinesigenic Dyskinesia and Progressive Ataxia-Spasticity Syndrome Caused by a Biallelic Variant in KCNJ10. [PDF]
Movement Disorders Clinical Practice, EarlyView.
Desjardins C +9 more
europepmc +2 more sources
MS Spasticity: Take Control (STC) for ambulatory adults: protocol for a randomized controlled trial
Background Spasticity affects 60–80% of people with multiple sclerosis (MS), impacting activity, participation and quality of life. We developed the group delivered spasticity self-management program, “MS Spasticity: Take Control” (STC), with DVDs for ...
Cinda L. Hugos, Michelle H. Cameron
doaj +1 more source
Stroke patients with spasticity usually require long-lasting care and interventions but frequently report that outpatient and community treatment is limited, reflecting a significant unmet need in health and social care provision.
Ganesh Bavikatte +4 more
doaj +1 more source
Canadian Physicians’ Use of Ultrasound in Spasticity Treatment: A National Cross-Sectional Survey
Objective: To identify potential barriers and obstacles preventing clinicians from adopting ultrasound for spasticity management. Design: A prospective, cross-sectional national survey. Setting: Web-based platform. Participants: Thirty-six physicians and
Fraser MacRae, BSc +8 more
doaj +1 more source
Assessing muscle architecture with ultrasound: implications for spasticity
Botulinum Neurotoxin Type A (BoNT-A) injections using Ultrasound (US) guidance have led to research evaluating changes in muscle architecture. Controversy remains as to what constitutes increased Echo-Intensity (EI) in spastic muscles and whether this ...
Ève Boissonnault +6 more
doaj +1 more source
Background: Multiple sclerosis (MS) treatment has radically improved over the last years; however, MS symptom management is still challenging. The novel Spasticity-Plus syndrome was conceptualized to frame several spasticity-related symptoms that can be ...
Oscar Fernandez +7 more
doaj +1 more source
SPG4 and Dementia: Expanding the Clinical Spectrum
ABSTRACT Objective Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing.
Emanuele Panza +19 more
wiley +1 more source
Any lesion in the descending tracts of the central nervous system (CNS), at any level (i.e. cortex, internal capsule, brain stem, or spinal cord), can lead to a combination of sensorimotor symptoms, including spasticity (Table 1).
Pandyan, A. +2 more
core +2 more sources
Background and purpose Randomized controlled trials and observational studies of nabiximols oromucosal spray in patients with multiple sclerosis (MS) spasticity have shown improvement in a range of associated symptoms (pain, spasms, fatigue, bladder ...
Michael Guger +2 more
doaj +1 more source

